Wspierają nas

Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.  Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. We work every day to deliver innovative medicines for patients with serious and life-threatening diseases.

Each day, our employees around the world work together for patients – it drives everything we do. We are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through our R&D organisation, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work.

As global citizens, we work sustainably, responsibly and seek to give back. Through the Bristol-Myers Squibb Foundation, we promote health equity and strive to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people.


Debiopharm is a Swiss-based, global biopharmaceutical company that develops innovative therapies targeting high unmet medical needs in oncology. Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, clinically demonstrate their safety and efficacy and then select large pharmaceutical commercialization partners to maximize patient access globally. For more information, please visit or


Merck jest wiodącą firmą naukowo -  technologiczną w  ochronie zdrowia, naukach przyrodniczych i chemii. Około 50.000 osób pracuje nad rozwojem technologii poprawiających jakość oraz długość życia - od terapii biologicznych w leczeniu nowotworów , czy stwardnienia rozsianego, najnowocześniejszych systemów dla badań naukowych oraz przemysłu do ciekłych kryształów wykorzystywanych przy produkcji smartfonów i telewizorów LCD.

Założona w 1668 roku firma Merck jest najstarszą na świecie firmą z branży farmaceutycznej i chemicznej. Rodzina założycieli pozostaje właścicielem większościowego pakietu akcji firmy. Merck, Darmstadt w Niemczech posiada pełne prawa do nazwy i marki Merck. Jedynymi wyjątkami są Stany Zjednoczone i Kanada, gdzie firma działa jako EMD Serono, MilliporeSigma i EMD Performance Materials.


For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.